Perfil de segurança fetal dos principais grupos farmacológicos utilizados no tratamento de doenças reumáticas inflamatórias

Translated title of the contribution: Fetal safety profile of drugs used in the treatment of inflammatory rheumatic diseases

Research output: Contribution to journalReview articlepeer-review

41 Downloads (Pure)

Abstract

The high prevalence of inflammatory rheumatic diseases in women of childbearing age increases the risk of exposure to antirheumatic agents during conception, pregnancy and breast feeding. The decision for pharmacological treatment initiation/ maintenance should be the result between the severity of maternal disease and the risk/benefits with treatment. The aim of this paper was to review recent literature about drug fetal safety profile, strength the importance of monitoring the pregnancy in patients with inflammatory rheumatic diseases and stress the need for further research in this area.
Translated title of the contributionFetal safety profile of drugs used in the treatment of inflammatory rheumatic diseases
Original languagePortuguese
Pages (from-to)323-331
Number of pages9
JournalActa reumatologica portuguesa
Volume32
Issue number4
Publication statusPublished - Oct 2007

Keywords

  • Pregnancy
  • Pharmacological Treatment
  • Fetal Safety
  • Rheumatic Diseases.
  • Gravidez
  • Fármacos
  • Segurança Fetal
  • Doenças Reumáticas

Fingerprint Dive into the research topics of 'Fetal safety profile of drugs used in the treatment of inflammatory rheumatic diseases'. Together they form a unique fingerprint.

Cite this